南微医学
(688029)
| 流通市值：126.21亿 | | | 总市值：126.21亿 |
| 流通股本：1.88亿 | | | 总股本：1.88亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,861,391,563.06 | 1,886,624,959.06 | 1,281,562,227.56 | 1,223,292,669.34 |
| 应收票据及应收账款 | 546,632,984.63 | 434,093,889.07 | 442,894,263.55 | 399,116,951.3 |
| 其中：应收票据 | 23,194,725.52 | 57,934.8 | 1,376,531 | - |
| 应收账款 | 523,438,259.11 | 434,035,954.27 | 441,517,732.55 | 399,116,951.3 |
| 预付款项 | 44,709,306.2 | 32,009,120.01 | 33,110,092.54 | 33,419,137.45 |
| 其他应收款合计 | 12,769,444.14 | 13,554,875.58 | 11,727,786.85 | 12,585,674.69 |
| 存货 | 615,988,795.17 | 536,582,311.14 | 538,926,006.78 | 519,153,526.11 |
| 其他流动资产 | 141,948,334.21 | 417,913,863.84 | 742,984,214.68 | 970,936,624.54 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,223,440,427.41 | 3,320,779,018.7 | 3,285,106,650.11 | 3,190,639,200.81 |
| 非流动资产: | | | | |
| 长期股权投资 | 63,442,686.57 | 59,795,713.32 | 56,257,718.23 | 52,538,694.02 |
| 其他权益工具投资 | 5,821,365.63 | 5,843,807.68 | 7,574,964.59 | 7,663,934.13 |
| 其他非流动金融资产 | 29,478,063 | 29,542,697.21 | 14,643,444.7 | 14,735,420.29 |
| 固定资产 | 928,114,385.28 | 926,465,628.26 | 671,098,760.62 | 438,779,187.04 |
| 在建工程 | 14,596,816.2 | 21,174,370.34 | 148,862,351.75 | 283,636,940.4 |
| 使用权资产 | 43,081,235.45 | 37,552,048.42 | 41,141,769.22 | 43,318,806.51 |
| 无形资产 | 71,658,431.53 | 74,816,455.63 | 73,171,848.9 | 78,561,109.43 |
| 商誉 | 405,889,569.89 | 169,599,585.22 | 174,497,411.76 | 180,179,934.34 |
| 长期待摊费用 | 44,374,765.46 | 44,976,574.13 | 40,841,827.57 | 29,369,980.02 |
| 递延所得税资产 | 38,507,097.43 | 33,451,790.09 | 31,024,904.8 | 28,236,395.29 |
| 其他非流动资产 | 62,830,644.74 | 55,609,260.81 | 22,376,407.89 | 68,041,907.87 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,707,795,061.18 | 1,458,827,931.11 | 1,281,491,410.03 | 1,225,062,309.34 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,931,235,488.59 | 4,779,606,949.81 | 4,566,598,060.14 | 4,415,701,510.15 |
| 流动负债: | | | | |
| 短期借款 | 11,211,046.31 | - | - | - |
| 应付票据及应付账款 | 439,646,636.66 | 510,109,777.07 | 323,625,505.96 | 283,653,044.62 |
| 其中：应付票据 | 29,433,478.82 | 49,891,077.5 | 30,406,399 | 10,415,459.11 |
| 应付账款 | 410,213,157.84 | 460,218,699.57 | 293,219,106.96 | 273,237,585.51 |
| 预收款项 | 1,599,722.3 | 1,116,809.7 | 1,405,081.39 | 1,186,943.53 |
| 合同负债 | 45,756,933.92 | 30,682,345.64 | 28,201,386.12 | 43,626,022.65 |
| 应付职工薪酬 | 72,217,987.56 | 144,064,326.06 | 93,460,157.19 | 89,806,701.64 |
| 应交税费 | 71,677,182.48 | 48,868,849.74 | 53,180,996.95 | 57,774,160.47 |
| 其他应付款合计 | 48,477,170.97 | 54,288,406.26 | 172,397,449.98 | 82,496,080.3 |
| 应付股利 | - | - | 93,542,250 | - |
| 一年内到期的非流动负债 | 12,554,088.46 | 14,253,281.59 | 13,750,500.59 | 14,652,179.52 |
| 其他流动负债 | 3,927,172.51 | 3,104,701.65 | 2,818,659.8 | 4,700,058.71 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 707,067,941.17 | 806,488,497.71 | 688,839,737.98 | 577,895,191.44 |
| 非流动负债: | | | | |
| 租赁负债 | 32,579,493.67 | 24,778,083.88 | 26,884,854.27 | 27,737,364.3 |
| 长期应付款 | 38,159,810.98 | 37,649,810.98 | 37,954,410.98 | 37,204,410.98 |
| 递延收益 | 8,406,620.39 | 9,495,128.01 | 8,570,864.55 | 9,138,528.8 |
| 递延所得税负债 | 1,826,315.38 | 1,831,975.55 | 2,060,951.95 | 2,083,141.86 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 80,972,240.42 | 73,754,998.42 | 75,471,081.75 | 76,163,445.94 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 788,040,181.59 | 880,243,496.13 | 764,310,819.73 | 654,058,637.38 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 187,847,422 | 187,847,422 | 187,847,422 | 187,847,422 |
| 资本公积 | 1,917,456,252.27 | 1,916,627,085.6 | 1,916,350,696.71 | 1,916,350,696.71 |
| 减:库存股 | 60,013,409.36 | 60,013,409.36 | 50,001,864.36 | 38,913,327.89 |
| 其他综合收益 | 14,344,807.89 | 7,740,813.41 | 5,153,670.86 | 3,915,523.9 |
| 盈余公积 | 109,690,385.48 | 109,690,385.48 | 109,690,385.48 | 109,690,385.48 |
| 未分配利润 | 1,825,137,303.8 | 1,664,200,364.1 | 1,562,067,329.36 | 1,514,978,884.7 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,994,462,762.08 | 3,826,092,661.23 | 3,731,107,640.05 | 3,693,869,584.9 |
| 少数股东权益 | 148,732,544.92 | 73,270,792.45 | 71,179,600.36 | 67,773,287.87 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,143,195,307 | 3,899,363,453.68 | 3,802,287,240.41 | 3,761,642,872.77 |
| 负债和股东权益合计 | 4,931,235,488.59 | 4,779,606,949.81 | 4,566,598,060.14 | 4,415,701,510.15 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-30 | 2024-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |